Company: PFSA
Filing Date: 2025-05-15
Form Type: 424B3
Source: 0001213900-25-044417
Chunk: 257

Company: Profusa, Inc.
Filing Date: 2025-05-15
Form: 424B3
Chunk 257
---
 due diligence on Company A subsequently began on June10, 2022, once Company A provided NorthView with virtual data room access. •On May18, 2022, a representative of the M&A group for HCW, who was acting as Profusa’s financial advisor and had been engaged to act as a placement agent in connection with any securities offering (including a private investment in public equity) that Profusa might enter into should it engage in a business combination with a special purpose acquisition company, introduced Jack Stover, Ben Hwang, Chief Executive Officer of Profusa, and suggested a meeting at the HCW Global Life Sciences Conference. On May25, 2022, Ben Hwang and Jack Stover met in person and shared interest in the opportunity of a business combination at a high level, noting that there was a good deal of mutual interest and expertise. This was followed by a call with the parties and the representative of HCW on May31, 2022, where more details of Profusa were shared and a mutual non -disclosureagreement was signed to further the diligence process with Profusa. Accordingly, NorthView was granted access to a virtual data room which was in the process of being updated. Additionally, Profusa and NorthView began exchange proposed terms for a potential transaction. HCW will receive a transaction fee in connection with the Business Combination. See “ Proposal 1 — Th e Business Combination Proposal — Related Agreements” for more information. •From June 1 to June3, 2022, NorthView management provided Profusa with drafts of a term sheet and discussed the proposed terms with Profusa’s management. Included in the term sheets were sources & uses of funds, pro forma cap tables, estimated fees and earnouts provisions based on various post -closestock price trading. •On June2, 2022, NorthView presented Profusa with an initial draft of a non -exclusiveletter of intent (“LOI”). •On June8, 2022, NorthView management presented the detailed terms of the two non -exclusiveletters of intent for Company A and Profusa to the NorthView Board of Directors who approved signing both letter of intent in substantially the form presented. •From June 2 through June12, 2022, there were various calls, meetings, discussions and negotiations related to the key terms of the letters of intent. The Profusa LOI, which valued Profusa at $155 million, was finalized on June10, 2022 and subsequently executed on June13